Retracted: Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance-Reference-Cited by-同舟云学术

Retracted: Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance

Published:2013-01-25 Issue:6 Volume:111 Page:934-940
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Kim Jeri¹,Ebertowski James²,Janiga Matthew³,Arzola Jorge⁴,Gillespie Gayle⁴,Fountain Michael⁵,Soderdahl Douglas²,Canby-Hagino Edith²,Elsamanoudi Sally⁶,Gurski Jennifer⁷,Davis John W.⁸,Parker Patricia A.⁹,Boyd Douglas D.¹⁰

Affiliation:

1. Department of Genitourinary Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. San Antonio Military Medical Center; San Antonio TX USA

3. 60th Medical Group; David Grant USAF Medical Center; Travis AFB; CA USA

4. 88th Medical Group; Wright-Patterson Medical Center; Wright-Patterson AFB; Dayton OH USA

5. 96th Medical Group; Eglin Regional Hospital; Eglin AFB; FL USA

6. Center for Prostate Disease Research; Walter Reed National Military Medical Center; Bethesda MD USA

7. Womack Army Medical Center; Fort Bragg NC USA

8. Department of Urology; The University of Texas MD Anderson Cancer Center; Houston TX USA

9. Department of Behavioral Sciences; The University of Texas MD Anderson Cancer Center; Houston TX USA

10. Department of Cancer Biology; The University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11768.x/fullpdf

Reference31 articles.

1. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?;Gosselaar;BJU Int,2005

2. Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression;Dall'Era;Nat Clin Pract,2008

3. Pathologic and clinical findings to predict tumor extent of nonpalpable (Stage T1c) prostate cancer;Epstein;JAMA,1994

4. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context;Draisma;J Natl Cancer Inst,2009

5. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005;Welch;J Natl Cancer Inst,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review;European Urology;2017-07

2. Young-age prostate cancer;Journal of Clinical Pathology;2015-04-02

3. Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study;BJU International;2015-03-26

4. Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?;Yonsei Medical Journal;2015

5. Overdiagnosis and Overtreatment of Prostate Cancer;European Urology;2014-06